Literature DB >> 1513060

Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma.

.   

Abstract

Clinical, pathological and follow-up data on the 1,147 cases of retinoblastoma registered in Japan from 1975 to 1982 were statistically analyzed. The cumulative survival rate of the total 1,147 cases was 93.0% at 5 years and 90.3% at 10 years, calculated by the Kaplan-Meier method. The survival rate for the 757 unilateral cases was 93.3% at 5 years and 92.3% at 10 years. For the 390 bilateral cases, however, the rate was 92.2% at 5 years and 86.7% at 10 years. The Cox multivariate analysis indicated that, among the various clinical and pathological findings in the patients, extraocular invasion by the tumor was the most significant risk factor which is predictive of death due to tumor. The survival rate for patients with extraocular invasion was significantly better in cases undergoing subsequent local radiation and/or systemic chemotherapy than in cases without such aftercare. The cumulative incidence rate of second neoplasms in 409 cases of hereditary retinoblastoma was 4.8% at 10 years, 9.8% at 15 years and 15.7% at 20 years. The occurrence of a second neoplasm was the main cause of death in the hereditary cases 10 years after the first onset.

Entities:  

Mesh:

Year:  1992        PMID: 1513060

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  9 in total

1.  The hourglass facial deformity as a consequence of orbital irradiation for bilateral retinoblastoma.

Authors:  N C Yue; M L Benson
Journal:  Pediatr Radiol       Date:  1996

2.  Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians.

Authors:  S Kaliki; A Ayyar; T V Dave; M J Ali; D K Mishra; M N Naik
Journal:  Eye (Lond)       Date:  2015-05-22       Impact factor: 3.775

3.  Retinoblastoma in Taiwan: survival rate and prognostic factors.

Authors:  Chia-Yau Chang; Tzeon-Jye Chiou; Betau Hwang; Li-Yuan Bai; Wen-Ming Hsu; Yuh-Lin Hsieh
Journal:  Jpn J Ophthalmol       Date:  2006 May-Jun       Impact factor: 2.447

4.  Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study.

Authors:  La-Ongsri Atchaneeyasakul; Chutima Wongsiwaroj; Mongkol Uiprasertkul; Kleebsabai Sanpakit; Kullathorn Thephamongkhol; Adisak Trinavarat
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

5.  Orbital retinoblastoma: Present status and future challenges - A review.

Authors:  Mohammad J Ali; Santosh G Honavar; Vijay A P Reddy
Journal:  Saudi J Ophthalmol       Date:  2010-10-13

6.  Early onset sebaceous carcinoma.

Authors:  Dongjin Sung; Sara A Kaltreider; Federico Gonzalez-Fernandez
Journal:  Diagn Pathol       Date:  2011-09-05       Impact factor: 2.644

Review 7.  Orbital retinoblastoma: An update.

Authors:  Santosh G Honavar; Fairooz P Manjandavida; Vijay Anand P Reddy
Journal:  Indian J Ophthalmol       Date:  2017-06       Impact factor: 1.848

Review 8.  Recent advances and challenges in the management of retinoblastoma.

Authors:  Bhavna Chawla; Rashmi Singh
Journal:  Indian J Ophthalmol       Date:  2017-02       Impact factor: 1.848

9.  Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017.

Authors:  Michał S Nowak; Bożena Romanowska-Dixon; Iwona Grabska-Liberek; Michał Żurek
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.